TMO
44
-2
MA
43
2
ESS
42
6
NTRS
64
15
DGX
46
3
SLB
42
-2
HST
52
-2
WYNN
45
-3
STI
35
-5
HRB
56
2
EFX
50
3
ACN
40
4
RL
56
-3
KMB
42
2
XRX
44
3
MO
44
2
CMI
67
2
EXR
37
6
STT
50
5
PFG
53
8
TMO
44
-2
MA
43
2
ESS
42
6
NTRS
64
15
DGX
46
3
SLB
42
-2
HST
52
-2
WYNN
45
-3
STI
35
-5
HRB
56
2
EFX
50
3
ACN
40
4
RL
56
-3
KMB
42
2
XRX
44
3
MO
44
2
CMI
67
2
EXR
37
6
STT
50
5
PFG
53
8
Financhill
Back

Toray Industries 10K Form

Buy
61

TRYIY
Toray Industries

Last Price:
$13.17
Seasonality Move:
2.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRYIY News And Ratings

See the #1 stock for the next 7 days that we like better than TRYIY

TRYIY Financial Statistics

Sales & Book Value

Annual Sales: $16.8B
Cash Flow: $262.1M
Price / Cash Flow: 20.43
Annual Sales: $14.61
Price / Book: 0.9

Profitability

EPS (TTM): 0.65270
Net Income (TTM): $520.6M
Gross Margin: $3.3B
Return on Equity: 4.2%
Return on Assets: 2.29%

Toray Industries Earnings Forecast

Key Toray Industries Financial Ratios

  • The Gross Profit Margin over the past 29 years for TRYIY is 19.74%.
  • The Selling, General & Administrative Expenses for TRYIY have been equal to 14.28% of Gross Profit Margin.
  • The Research & Development expenses have been 2.83% of Revenue.
  • The Interest Expense is 28.12% of Operating Income.
  • The Net Earning history of TRYIY is 3.04% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Toray Industries Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Chemicals
Sector: Materials
Current Symbol: TRYIY
Website: toray.co.jp

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 1.7
Quick Ratio: 1

Price-to-Earnings

Trailing P/E Ratio: 20.91
Forward P/E Ratio: 0

TRYIY Technical Analysis vs Fundamental Analysis

Buy
61
Toray Industries (TRYIY) is a Buy

Is Toray Industries a Buy or a Sell?

  • Toray Industries stock is rated a Buy
    The current Toray Industries [TRYIY] share price is $13.41. The Score for TRYIY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.